Industry News

Flourish Expands with Acquisition of Keystone Clinical Studies

By admin| 1 Min Read | October 20, 2022
FacebookLinkedInTwitter

Flourish Research is excited to announce the acquisition of Keystone Clinical Studies, expanding our rapidly growing footprint across the nation. Keystone, located in the greater Philadelphia area, is a leader in Alzheimer’s Disease and other types of CNS research. This addition allows Flourish to diversify our areas of expertise and reach in these core areas of research. 

FacebookLinkedInTwitter
Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.